Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pharma Spreads Its Bets On Multiple Modalities In Advanced Products

Jun 22 2022

• By Pascal Joly, Ana Costa, and Markus Thunecke

Blue Dice

Related Content

Bayer Bids To Be A Winner In Cell & Gene Therapy

Dec 08 2020

Bayer Boosts Gene Therapy Presence With AskBio Buy

Oct 26 2020

Caribou Hit By Familiar Allo CAR-T Durability Problems

Jun 13 2022

Roche $4.8bn Buy Sparks Hemophilia Gene Therapy Race

Feb 25 2019

Astellas To Pay $3bn For Gene Therapy Company Audentes

Dec 03 2019

Janssen/Legend Plan Phased US Launch For BCMA-Targeting CAR-T Carvykti

Mar 01 2022

Novartis Goes Big On Gene Therapy With $8.7bn AveXis Acquisition

Apr 09 2018

Related Companies

Johnson & Johnson

Pfizer Inc.

Moderna, Inc.

Novartis AG

CRISPR Therapeutics AG

Intellia Therapeutics, Inc.

Fate Therapeutics, Inc.

Rubius Therapeutics, Inc.

Takeda Pharmaceutical Co. Ltd.

Roche Holding AG

Sanofi

BioNTech SE

Merck & Co., Inc.

The Medicines Company

Novo Nordisk A/S

Dicerna Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.

Regulus Therapeutics Inc.

Gilead Sciences, Inc.

Kite Pharma, Inc.

Juno Therapeutics Inc.

Allogene Therapeutics Inc.

Celyad Oncology SA

Biogen, Inc.

Boehringer Ingelheim GmbH

Amgen, Inc.

Adaptimmune Therapeutics plc

Genentech, Inc.

Immunocore, Ltd.

Bristol Myers Squibb Company

Janssen Pharmaceuticals Inc.

Bayer AG

Regenxbio Inc.

Additional Topics

Gene Therapy Research & Development Innovation Regenerative Medicine Cancer BioPharmaceutical

More from Innovation

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window